Screening and Management of Older Patients with HIV

Volume 1, Issue 2.

Dr. Kelly Gebo, Associate Professor of Medicine and Epidemiology at the Johns Hopkins Unviersity School of Medicine will discuss the screening of older patients for HIV risk factors. She will also explain the issues of polypharmacy in older HIV infected patients.

Occult Hepatitis B Virus Infection

Volume 2, Issue 6.

Dr. Kennenth Sherman, Gould Professor of Medicine and Director of the Division of Digestive Disease at the University of Cincinnati College of Medicine will diferentiate how occult HBV differs from classical HBV infections.

Featured Cases: The Role of Exercise and Physical Activity in Optimizing Outcomes Among Patients with CF

Volume 3, Issue 10.

Dr. Elizabeth Yen offers a clinical perspective to her review on how new research that highlights the strong positive impact of early behavioral and nutritional education and predictors of long-term response to such interventions. In this podcast she will expand on that information by discussing case scenarios.

Dr. Tram T. Tran will cover issues related to Hepatitis B and Pregnancy

Volume 2, Issue 4-Hepatitis B and Pregnancy.

Dr. Tram T Tran, Medical Director of the Liver Transplantation Program at the Liver Disease and Transplant Center at Cedars-Sinai Medical Center and Associate Professor of Medicine at the David Geffen School of Medicine at UCLA will present patient case scenarios which: review current screening recommendations for hepatitis B, Assess strategies to reduce mother-to-child transmission (MTCT) of hepatitis B, and review recommendations and vaccination of hepatitis B infected mothers.

Featured Cases: Interventions to Improve Nutrition in Patients with CF

Volume 3, Issue 8.

In this issue, Dr. Elizabeth Yen reviews new research highlighting the strong positive impact of early behavioral and nutritional education. Exploring predictors of long-term response to such interventions she discusss how body image may affect compliance with nutritional recommendations in adolescents; and, then present data describing positive outcomes with gastrostomy tube placement for supplemental enteral intake.

Featured Cases: Exacerbation Therapies

Volume 3, Issue 4.

This podcast has been developed for clinicians caring for patients with issues related to cystic fibrosis. You can also read the companion newsletter. In this edition Dr. Chris Goss will explain the use of new inhalation therapies for the treatment of cystic fibrosis, with the discussion some typical case scenarios.

Featured Cases: New Inhalation Therapies

Volume 2, Issue 12.

The eCysticFibrosis Review podcast is a clinical discussion between our November authors, Michael Boyle, MD, Elliott Dasenbrook, MD and Robert Busker, eCysticFibrosis Reviews Medical Editor. The topic is Emerging Pathogens in Cystic Fibrosis. Participants can now receive 0.5 credits per podcast after completing an online post-test via the links provided on the website page,

Featured Cases: State-of-the-Art Treatment for CF Lung Disease

Volume 2, Issue 10.

Clinical practice guidelines have become a regular component of health care. The Cystic Fibrosis Foundation has supported the development of several recent clinical practice guidelines to review the evidence that endorses many of the therapies currently in use.

Although numerous clinical manifestations of cystic fibrosis (CF) exist, the principal causes of disease-related morbidity and mortality are due to pancreatic insufficiency and chronic airway infection. Recommendations are now available on the assessment and treatment of nutritional disease, use of airway clearance therapies, and use of chronic medications to maintain lung health. Acute complications of CF lung disease include pulmonary exacerbations, hemoptysis, and pneumothorax; guidelines on the management of these complications are currently available as well. Finally, as newborn screening for CF has become standard in all states, we can expect that most patients will be diagnosed in the absence of symptoms. Infant care guidelines should provide primary care physicians with the information needed for appropriate assessment and treatment of newly diagnosed patients.

In this podcast recording, Dr. Patrick Flume utilizes patient cases to summarize the clinical practice guidelines for individuals with CF, to aid clinicians in improving the quality and consistency of the care they provide.

Featured Cases: Vitamin D and Bone Health

Volume 2, Issue 8.

In 2002, the CF Foundation convened a consensus conference. This consensus conference developed specific recommendations for the prevention of bone disease and the optimal supplementation of vitamin D for patients with cystic fibrosis. The original consensus guidelines did not have any actual demonstration in cystic fibrosis patients, and most of this was expert opinion. And at this time we are actually trying to test these guidelines to see if they hold true in those with cystic fibrosis. Since patients with cystic fibrosis are living longer, they are developing more complications, such as bone disease, and insuring that vitamin D supplementation is adequate and figuring out new ways to prevent bone disease is becoming more and more important for CF patients. In the discussion today, Peter Mogayzel, MD and Dianna Green, MD, of the Johns Hopkins University School of Medicine, will focus on the basis of the current vitamin D recommendation for patients with cystic fibrosis, describe the potential for success of various strategies for treatment of vitamin D insufficiency, and compare the potential benefits and risks of using bisphosphonates for the treatment of osteoporosis in patients with cystic fibrosis.